Perspective Therapeutics (CATX) EPS (Basic) (2010 - 2026)
Perspective Therapeutics (CATX) reported EPS (Basic) of -$0.28 for Q1 2026, down 4132.2% sequentially from $0.01 in Q2 2025.
Perspective Therapeutics (CATX) EPS (Basic) (2010 - 2026) Analysis & Trends
Perspective Therapeutics (CATX) has 17 years of EPS (Basic) data on file, last reported at -$0.28 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) changed N/A year-over-year to -$0.28; the trailing twelve-month figure through Mar 2026 stood at -$0.27 (down 3949.44% YoY), and the FY2025 full-year result was $0.01, up 147.27% from the prior year.
- EPS (Basic) slipped to -$0.28 in Q1 2026, from $0.01 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.01 in Q2 2025 to a low of -$0.53 in Q3 2022.
- A 5-year average of -$0.13 and a median of -$0.08 in 2022 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) sank 233.69% in 2022 and soared 194.18% in 2025, its largest moves.
- Tracing CATX's EPS (Basic) over 5 years: stood at -$0.16 in 2022, then dropped by 20.93% to -$0.19 in 2023, then surged by 96.2% to -$0.01 in 2024, then soared by 194.18% to $0.01 in 2025, then slumped by 4132.2% to -$0.28 in 2026.
- Business Quant data shows CATX's EPS (Basic) at -$0.28 in Q1 2026, $0.01 in Q2 2025, and -$0.01 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.62 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 1.95 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.98 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 0.52 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.19 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 0.90 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Perspective Therapeutics | 146.05 Mn | 146.05 Mn | - | -0.28 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.28 |
| Jun 30, 2025 | 0.01 |
| Jun 30, 2024 | -0.01 |
| Mar 31, 2024 | -0.01 |
| Dec 31, 2023 | -0.19 |
| Sep 30, 2023 | -0.03 |
| Jun 30, 2023 | -0.06 |
| Mar 31, 2023 | -0.06 |
| Dec 31, 2022 | -0.16 |
| Sep 30, 2022 | -0.53 |
| Jun 30, 2022 | -0.15 |
| Mar 31, 2022 | -0.09 |
| Dec 31, 2021 | -0.11 |
| Sep 30, 2021 | -0.16 |
| Jun 30, 2021 | -0.10 |
| Mar 31, 2021 | -0.06 |
| Dec 31, 2020 | -0.10 |
| Sep 30, 2020 | -0.10 |
| Jun 30, 2020 | -0.18 |
| Mar 31, 2020 | -0.08 |